Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.50% is 78% below its 5-year average of 6.80%, near the low end of its 5-year range (0.79%–8.40%).
As of the fiscal period ended Tuesday, June 30, 2026. 40.43% below its 12-month average of 2.51%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.50%.
DEBT TO ASSETS RATIO
1.50%
DEBT TO ASSETS RATIO AVG TTM
2.51%
DEBT TO ASSETS RATIO AVG 3Y
5.54%
DEBT TO ASSETS RATIO AVG 5Y
6.80%
DEBT TO ASSETS RATIO AVG 10Y
4.61%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-40.43%
CURRENT VS 3Y AVG
-72.99%
CURRENT VS 5Y AVG
-78.00%
CURRENT VS 10Y AVG
-67.55%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 638 covered companies
CURRENT VS SECTOR MEDIAN
+1396.23%
vs the sector median at left
CytomX Therapeutics, Inc.
Market Cap
$563.87M
Debt to Assets Ratio
1.50%
TTM Avg
2.51%
3Y Avg
5.54%
5Y Avg
6.80%
Market Cap
$562.43M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$560.00M
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$568.37M
Debt to Assets Ratio
0.45%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$554.35M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$545.59M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$582.66M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$537.16M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | $563.87M | 1.50% | 2.51% | 5.54% | 6.80% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $562.43M | 0.19% | N/A | N/A | N/A |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| CorMedix Inc. (CRMD)vs › | $564.07M | 0.16% | N/A | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $568.37M | 0.45% | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $554.35M | 0.00% | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $545.59M | 0.00% | N/A | N/A | N/A |
| OrthoPediatrics Corp. (KIDS)vs › | $582.66M | 0.18% | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $537.16M | 0.02% | N/A | N/A | N/A |
| Immix Biopharma, Inc. (IMMX)vs › | $534.50M | 0.00% | N/A | N/A | N/A |
Debt/Assets
1.5%
Debt/Equity
0.02
Current Ratio
9.36
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.50% |
| 2026-03-31 | 0.79% |
| 2025-12-31 | 2.80% |
| 2025-09-30 | 3.54% |
| 2025-06-30 | 3.93% |
| 2025-03-31 | 8.27% |
| 2024-12-31 | 7.79% |
| 2024-09-30 | 7.62% |
| 2024-06-30 | 7.38% |
| 2024-03-31 | 6.97% |
| 2023-12-31 | 6.92% |
| 2023-09-30 | 6.81% |
| 2023-06-30 | 7.69% |
| 2023-03-31 | 7.28% |
| 2022-12-31 | 6.92% |
| 2022-09-30 | 8.40% |
| 2022-06-30 | 7.66% |
| 2022-03-31 | 7.01% |
| 2021-12-31 | 6.39% |
| 2021-09-30 | 6.07% |
| 2021-06-30 | 5.80% |
| 2021-03-31 | 5.55% |
| 2020-12-31 | 6.93% |
| 2020-09-30 | 6.83% |
| 2020-06-30 | 6.54% |
| 2020-03-31 | 6.19% |
| 2019-12-31 | 8.11% |
| 2019-09-30 | 7.61% |
| 2019-06-30 | 7.14% |
| 2019-03-31 | 6.65% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 1.71% |
| 2015-03-31 | 6.05% |
| 2014-12-31 | 4.09% |
